Osteoarthritis and Pain: Intensive Training in Pain Management - Final Assessment Module

Launch Date:
March 16, 2021
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Primary care, Rheumatologists, Orthopedists, Pain specialists, PM&R

Relevant Terms:

osteoarthritis

The self-assessment covers all elements of the curriculum, including the group discussions and group tasks.

Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP

Pain Management Nurse Practitioner
Ponte Vedra Beach, Florida

Yvonne D’Arcy MS, APRN, CNS, FAANP is a pain management and palliative care nurse practitioner and consultant. She has extensive clinical experience in various roles, including leading a nurse practitioner pain management consulting service at Suburban Hospital Johns Hopkins Medicine, Bethesda, Maryland; pain service coordinator at Johns Hopkins Hospital Oncology department, Baltimore, Maryland; and supervisor of the chronic pain clinic and coordinator of the acute pain service at the Mayo Clinic, Jacksonville, Florida. Ms. D’Arcy has received numerous awards and was inducted as a fellow of the American Association of Nurse Practitioners in 2016. She is a prolific speaker and author, delivering more than 100 poster and oral presentations, publishing more than 100 journal articles on pain-related topics, and authoring eight books, including the AJN award-wining and highly reviewed Compact Clinical Guide to Pain series by Springer Publishing Company. Ms. D’Arcy has been a member of the American Pain Society, where she served on the education committee and helped draft and review national pain management guidelines, a past member of the board of the American Society of Pain Management Nurses  as well as the immediate past co-chair of the  Pain Special Practice Group of the American. Association of Nurse Practitioners.

Bill McCarberg, MD

Neighborhood Healthcare
Escondido, CA

Bill McCarberg MD is Founder of the Chronic Pain Management Program for Kaiser Permanente (retired) in San Diego, California. He is currently working with Neighborhood Healthcare in Escondido California (Federally Qualified Health Center) and Elizabeth Hospice. He is past president of the American Academy of Pain Medicine and president of the Western Pain Society. His is also Adjunct Assistant Clinical Professor at the University of California at San Diego School Medicine. Dr. McCarberg is a member of the American Academy of Family Physicians, the American Academy of Pain Medicine. Several of his award and leadership positions include national guideline committees for post-operative pain, fibromyalgia and osteoarthritis; the Elizabeth Narcessian Award for Outstanding Educational Achievement in the Field of Pain, American Pain Society; Presidential Commendation, American Academy of Pain Medicine; Award of Honor for Excellence in Geriatric Medicine, the National Institute of Medicine; Mayday Pain and Society Fellowship; Award of Excellence, Southern California Pain Initiative; Highest Rated Physician, Member Appraisal of Physician Services, Kaiser Permanente; Ambassador of the Year, National Pain Foundation. He has served the field as Board of Directors of the American Pain Society and recently on the Professional Education and Training Sub-committee of the NIH’s Interagency Pain Research Coordinating Committee, that has proposed the US Department of Health and Human Service’s National Pain Strategy. He has given more than 250 presentations on pain management issues and is the author or co-author of 115 articles, book chapters and books. He is board certified by the American Board of Pain Medicine, the American Board of Family Practice and additionally certified in Geriatrics and Hospice and Palliative Care. Dr McCarberg received his MD degree from Northwestern University Medical School in Chicago, Illinois. He completed a medical internship and a residency in family practice at Highland Hospital in Rochester, New York
1.
Describe current nonpharmacologic and pharmacologic osteoarthritis treatments and identify how they are failing to meet patients’ needs.
2.
Evaluate the nerve growth factor (NGF) pathway and how medications blocking NGF may benefit patients with osteoarthritis.
3.
Identify benefits and risks of in-development NGF-sequestering agents for treating osteoarthritis pain.
4.
Identify manifestations of the burden of osteoarthritis pain, including comorbidities and racial and gender disparities in presentation and treatment, and evaluate their impact on patient quality of life.